Megestrol Acetate (Borea)
535
relevant articles (68 outcomes,
180 trials/studies)
found for this Drug
Description:
Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)
Also Known As:
Borea; Megace; Apo-Megestrol; Apotex Brand of Megestrol Acetate; Bristol-Myers Brand of Megestrol Acetate; Bristol-Myers Squibb Brand of Megestrol Acetate; Lemery Brand of Megestrol Acetate; Lin-Megestrol; Linson Pharma Brand of Megestrol Acetate; Madaus Brand of Megestrol Acetate; Maygace; Megefren; Megestat; Megostat; Mestrel; Nu-Megestrol; Nu-Pharm Brand of Megestrol Acetate; Prasfarma Brand of Megestrol Acetate; Squibb Brand of Megestrol Acetate; Acetate, Megestrol; Apo Megestrol; ApoMegestrol; Bristol Myers Brand of Megestrol Acetate; Bristol Myers Squibb Brand of Megestrol Acetate; Lin Megestrol; LinMegestrol; Nu Megestrol; Nu Pharm Brand of Megestrol Acetate; NuMegestrol
Relationship Network
Drug Context: Research Results
Experts
| 1. | Jatoi, Aminah:
4 articles
(10/2006 - 01/2002)
|
| 2. | Evans, William J:
3 articles
(02/2007 - 05/2002)
|
| 3. | Sloan, Jeff A:
3 articles
(06/2004 - 01/2002)
|
| 4. | Novotny, Paul J:
3 articles
(06/2004 - 01/2002)
|
| 5. | Mailliard, James A:
3 articles
(06/2004 - 01/2002)
|
| 6. | Loprinzi, Charles L:
3 articles
(06/2004 - 01/2002)
|
| 7. | Schuster, M W:
3 articles
(01/2001 - 01/2000)
|
| 8. | Wu, S Y:
3 articles
(01/2001 - 01/2000)
|
| 9. | Olson, J S:
3 articles
(01/2001 - 01/2000)
|
| 10. | Stevens, M R:
3 articles
(01/2001 - 01/2000)
|
Related Diseases
| 1. | Breast Neoplasms (Breast Cancer)
|
| 2. | Neoplasms (Cancer)
|
| 3. | Anorexia
|
| 4. | Cachexia
|
| 5. | Weight Gain
04/01/2002
- " CONCLUSIONS: Short-term use of megestrol acetate results in significant weight gain and improved pulmonary function in malnourished subjects with CF" 10/01/1994
- " Megestrol acetate-treated patients had a significantly greater mean maximum weight gain (p = 0.027) and appetite stimulation (p = 0.021) than did placebo-treated patients" 09/15/1994
- " Compared with patients receiving placebo at the time of maximum weight change, evaluable patients receiving megestrol acetate, 800 mg/d, reported improvement in overall well-being and had an increase in mean weight gain (-0.725 compared with 3.54 kg [-1.6 compared with +7.8 pounds]; P < 0.001), lean body mass (-0.772 compared with +1.14 kg [-1.7 compared with +2.5 pounds]; P < 0.001), appetite grade (P < 0.001), and caloric intake (-107 compared with +645.6 calories/d; P = 0.001)" 09/01/2000
- " The purpose of this study was to determine whether the administration of megestrol acetate (MA) induces weight gain in malnourished patients with CF, and to assess the composition of weight gain" 01/01/1995
- " The second study, enrolling 271 patients, showed a dose-dependent, step-wise relationship between megestrol acetate administration and weight gain"
Order ALL the reference details at left...
|
|
Related Drugs and Biologics
Related Therapies and Procedures